Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / W••••••• L•••••••••

S••• S••••• Capital Acquires W••••••• L•••••••••

Platform acquisitionannouncedannounced Oct 17, 2022Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
consumer / beauty, consumer, pet
Target location
unknown
Seller kind
Founder
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • The company employs an impressive formulary team of industry veterans with decades of experience in developing cutting-edge products,” said D•••• F•••••••, Founder and CEO of S••• S••••• Capital.
  • DALLAS–S••• S••••• C•••••• L•• (“SSC”), an industrial-focused private equity firm, announced today that it has acquired W••••••• L••••••••• (“W•••••••”), a contract manufacturer of consumer staple products in the beauty, personal care, pet and over-the-counter drug end markets.
Side not stated
  • T••• D• V••Managementconfirmed
    “The opportunity to collaborate with S••• S••••• is a testament to the hard work of our team to build a strong brand within the contract manufacturing space,” said T••• D• V••, Founder of W••••••• L•••••••••.
  • S••• S••••• Capital Acquires W••••••• L•••••••••
Evidence
S••• S••••• Capital Acquires W••••••• L•••••••••
S••• S••••• Capital Acquires W••••••• L••••••••• | Private Equity Intelligence | DFX